Patient Information Leaflet
Alprazolam Normon 0.5 mg Tablets EFG
Alprazolam
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What Alprazolam Normon is and what it is used for
2. What you need to know before you start taking Alprazolam Normon
3. How to take Alprazolam Normon
4. Possible side effects
5. Storage of Alprazolam Normon
6. Contents of the pack and additional information
Alprazolam belongs to a group of medicines called benzodiazepines (anxiolytic medicines).
This medicine is used in adults for the treatment of severe, debilitating, or highly distressing anxiety symptoms. This medicine is only for short-term use.
Do not take Alprazolam Normon
Warnings and precautions
Consult your doctor or pharmacist before starting to take Alprazolam Normon.
Taking Alprazolam Normon with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Taking Alprazolam Normon with food, drinks, and alcohol
During treatment, avoid alcoholic beverages. The effect of alcohol may potentiate sedation, and this may affect your alertness (see section "Driving and operating machines").
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Alprazolam is not recommended during pregnancy or breastfeeding, unless, at the doctor's discretion, the benefit outweighs the risk for the child.
Use in children and adolescents (under 18 years)
Alprazolam is not recommended for children and adolescents under 18 years. Benzodiazepines should not be administered to children unless it is strictly necessary and prescribed by a doctor. The efficacy and safety of alprazolam have not been established in children under 18 years.
Use in elderly patients (over 65 years)
This medication may affect this group of patients more than young patients. If you belong to this group, your doctor may reduce the dose and check your response to treatment. Please follow their instructions carefully (see section "How to take Alprazolam Normon").
Benzodiazepines and related products should be used with caution in elderly patients, due to the risk of sedation and/or muscle weakness that may cause falls, often with serious consequences in this population.
Special patient groups
If your liver or kidneys do not function well, consult your doctor, who may advise you to use a lower dose of Alprazolam Normon. If you have respiratory problems, inform your doctor.
Driving and operating machines
Alprazolam may affect your ability to drive or operate machinery, as it may cause drowsiness, decrease your attention, or decrease your reaction time. The appearance of these effects is more likely at the beginning of treatment or when the dose is increased. Do not drive or operate machines if you experience any of these effects.
These effects may be potentiated if alcohol is consumed simultaneously.
Alprazolam Normon contains lactose and sunset yellow (E-110)
This medication contains lactose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication may cause allergic reactions.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Dosage:
The tablets or their part will be ingested without chewing, with the help of a little liquid.
Your doctor will prescribe the Alprazolam Normon presentation most suitable for you, according to the dose you need.
The usual doses are as follows:
In elderly patients, with chronic respiratory insufficiency, liver or kidney impairment, the recommended initial dose is 0.25 mg of alprazolam, 2 or 3 times a day, with the amount of alprazolam ingested per day ranging from 0.5 mg to 0.75 mg in divided doses, which can be gradually increased as needed and well tolerated.
Each individual dose should not exceed the indicated limits, and the total daily dose should not either, unless your doctor indicates otherwise.
Duration and discontinuation of treatment:
The maximum duration of treatment should not exceed 2-4 weeks. Long-term treatment is not recommended. If your doctor considers it necessary to prolong treatment in your case, they will do so for limited periods and will frequently monitor your situation.
You should never discontinue treatment abruptly. Your doctor will indicate the duration of treatment based on the evolution of your disease and will explain how to gradually reduce the dose until you complete your treatment.
If you estimate that the action of Alprazolam Normon is too strong or too weak, inform your doctor or pharmacist.
If you take more Alprazolam Normon than you should
If you have taken more alprazolam than you should, consult your doctor or pharmacist immediately or go to the nearest hospital with this leaflet.
Symptoms include somnolence (drowsiness), speech disorders (dysarthria), coordination disturbances, confusion, lethargy (a state of deep and prolonged somnolence), muscle tone decrease (hypotonia), blood pressure drop, respiratory depression, rarely coma, and very rarely death. Serious sequelae are rare, unless alprazolam is taken with other medications or alcohol.
In case of overdose or accidental ingestion, consult the Toxicological Information Service at phone number 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Alprazolam Normon
Do not take a double dose to compensate for the missed doses. If the missed dose is recent, take your dose immediately, and if not, wait for the next dose, without taking a double dose to compensate.
If you interrupt treatment with Alprazolam Normon
Alprazolam treatment can produce dependence, thereforewhen discontinuing alprazolam administration abruptly, withdrawal symptoms may appear.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The side effects that may occur during treatment with alprazolam predominantly occur at the beginning of treatment and generally disappear with continued administration or after a dose reduction.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Unknown frequency (cannot be estimated from available data):
With the use of benzodiazepines, the following may occur:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Alprazolam Normon
Appearance of the product and contents of the packaging
Alprazolam Normon 0.5 mgare orange-colored, round, flat, tablets with a breaking bar on one face andengraved with APon the other.
They are presented in packaging containing 30 tablets and clinical packaging of 500 tablets. Each tablet contains 0.5 mg of alprazolam. Only some packaging sizes may be marketed.
Holder of the marketing authorization and responsible manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of the last review of this leaflet:April 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information on this medication by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/63246/P_63246.html
.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.